DermTech, Inc. stock is up 8.51% since 30 days ago. The next earnings date is Feb 29, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 57.14% of the previous 6 December’s closed higher than November. In the last 2 Unusual Options Trades, there were 2 PUTs.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
19 Oct 14:02 | 19 Jan, 2024 | 5.00 | 641 | ||
30 Oct 14:45 | 19 Jan, 2024 | 5.00 | 641 |
DermTech, Inc. develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. The company sells its products primarily to pathology and oncology practitioners.